Sinovent
Suzhou
About Sinovent
Founded in 2016, Sinovent is a global biopharmaceutical company focused on innovation. Sinovent is centered around global standard excellence through its advanced biotechnology platform, decades of management experience, as well as financial support. Sinovent uniquely combines its expertise in science, management and finance, to develop and promote advanced treatment methods to solve worldwide healthcare problems. Currently, the company has 12 products in development, primarily in oncology, auto-immune diseases, and infectious diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $242.0M
- Funding stage: Late Stage Venture
- Last round: Series E (Feb 2024)
- Website: sinovent.com.cn
- Phone: +0512-88869230
Industries & Categories
Biotechnology, Life Science
Canonical: https://fsome.com/organization/sinovent-112645 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.